Apply on Employer Site

Elanco · 3 weeks ago

Sr. Specialist - Downstream Operations Technician (Day Shift)

Elwood, KS

Full-time

Hybrid

Mid, Senior Level

3+ years exp

Elanco is a global leader in animal health dedicated to innovation and delivering products and services for farm animals and pets. They are seeking a Sr. Specialist - Downstream Operations Technician who will be responsible for manufacturing execution, changeover, and production control in downstream operations, ensuring accurate process documentation and leading the operations team.

ManufacturingPetSupply Chain Management

No H1B

Hiring Manager

Madison Collins, MBA

Responsibilities

Executes the operation with team serving as process leader, coach, trainer, and responsible party

Performs and verifies Maintenance, process setup, troubleshooting, change over, process intervention

Operations representative for cross-functional process support team, engaging in process

Real-time problem solving, process intervention, and technical experiment delivery

Ensures process documentation is prepared and completed with accuracy and concurrence

Qualification

Liquid Protein A ChromatographyTangential Flow FiltrationProduction scale filtrationGMP manufacturingSAPRoot Cause Investigation training

Required

Education: High School Diploma / GED

Experience: A minimum of 3 years of experience in Liquid Protein A Chromatography at manufacturing scale

Preferred

Production scale filtration

Formal Root Cause Investigation training

Proficiency with SAP

GMP manufacturing

Tangential Flow Filtration

Benefits

Multiple relocation packages

Two weeklong shutdowns (mid-summer and year-end) in the US (in addition to PTO)

8-week parental leave

9 Employee Resource Groups

Annual bonus offering

Flexible work arrangements

Up to 6% 401K matching

Company

Elanco

Elanco is an animal health company that manufactures and markets a diverse range of products to promote animal health and well-being.

Founded in 1954

Greenfield, Indiana, USA

5001-10000 employees

https://www.elanco.com

Funding

Current Stage

Public Company

Total Funding

$252.86M

Key Investors

AncoraBill & Melinda Gates Foundation

2023-12-30Post Ipo Equity· $250M

2018-09-19IPO

2017-05-24Grant· $2.86M

Leadership Team

Dave Kinard

Executive Vice President Human Resources, Corporate Affairs & Administration

Jennifer Black

Senior Director, Global Indirect Procurement

Recent News

PR Newswire

Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis

2026-01-03

thefly.com

Elanco receives USDA approval for Befrena

2026-01-03

thefly.com

Elanco's Credelio Quattro tablets granted FDA conditional approval

2025-12-18

Company data provided by crunchbase